your visual experiments

With Reshape, the world's first AI and robotics powered imaging and analysis platform, researchers can finally automate visual assays and accelerate the pace of research.

Get in touch
See how it works

Unlock your lab's potential

Our platform combines flexible robotics and machine learning to dramatically accelerate your time to market.

Automated imaging

Run experiments 24/7 and free up time for laboratory technicians.

34° C
20° C
40° C

Built-in incubation

Flexible temperature control and accurate logging to ensure repeatability.


Increase accuracy and repeatability with our image analysis models.

Scalable robotic platform

Easily add more machines to supercharge your throughput and get to market faster.

Managed data storage

Keep your data secure with browser-based access for easy collaboration.

Ultimate assay flexibility

Compatible with the plate formats you use today.


Never miss a data point

Our imaging system captures everything that happens during incubation with pre-calibrated imaging profiles.


Scalable data acquisition

Increase the quality of your models with our scalable image assessment infrastructure to produce high quality data faster.

Food & ingredients

Supercharge your functional ingredient characterization, stability testing, acidification and many other assays.


Automate competition assays for pesticide development across fungi, insects, seed health and more.


Enable automated high throughput microbial discovery or do library and enzyme screens with much higher resolution.

Accelerating R&D
for global companies

“The Reshape Imaging System has been transformative for our research. I highly recommend it for any lab involved in synthetic biology and metabolic engineering."

Rodrigo Ledesma Amaro

Imperial College

“I would most certainly recommend the Reshape Microbiology Platform. The communication with Reshape has been great, and it has given us a lot of new capabilities we didn’t have before”

Anja Kristiansen

Senior scientist
Chr. Hansen

"The flexibility of the equipment means that we’ve been able to improve a lot of our other assays as well and even develop new ones based on new functionality."

Morten Nørholm

PI, DTU Biosustain
CSO, CloneOpt

Let's talk

Leave your details to book a meeting.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.